Risma (CAS:RIS) Other Long-Term Liabilities: MAD29 Mil (As of Dec. 2025)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Valuation Modestly Undervalued

5 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Risma Other Long-Term Liabilities?

Risma CAS:RIS +1.23% 74 Other Long-Term Liabilities is MAD29 Mil as of Dec. 2025. GuruFocus rates CAS:RIS with a GF Score™ of 74/100 and a GF Value™ of MAD360.85 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Risma's other long-term liabilities for the quarter that ended in Dec. 2025 was MAD29 Mil.

Risma's quarterly other long-term liabilities increased from Dec. 2024 (MAD4 Mil) to Jun. 2025 (MAD5 Mil) and increased from Jun. 2025 (MAD5 Mil) to Dec. 2025 (MAD29 Mil).

Risma's annual other long-term liabilities increased from Dec. 2023 (MAD3 Mil) to Dec. 2024 (MAD4 Mil) and increased from Dec. 2024 (MAD4 Mil) to Dec. 2025 (MAD29 Mil).

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Risma Other Long-Term Liabilities Related Terms

Risma Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Risma's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Risma Other Long-Term Liabilities Chart

Risma Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Other Long-Term Liabilities

Get a 7-Day Free Trial

0.00

-0.00

3.40

3.95

28.81

Risma Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Other Long-Term Liabilities	Get a 7-Day Free Trial															3.40	3.00	3.95	5.00	28.81

74GF Score

Risma SA CAS:RIS

Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Risma Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Frequently Asked Questions Learn more about Other Long-Term Liabilities →

What does a Other Long-Term Liabilities of MAD29 Mil mean?

Risma (CAS:RIS) has a Other Long-Term Liabilities of MAD29 Mil as of Dec. 2025. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Risma and its competitors.

Is Risma's Other Long-Term Liabilities too high?

Risma's current Other Long-Term Liabilities is MAD29 Mil. Overall, Risma has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Risma's Other Long-Term Liabilities compare to MAR and HLT?

Risma's Other Long-Term Liabilities of MAD29 Mil can be compared against companies in the Travel & Leisure industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Other Long-Term Liabilities for a Travel & Leisure company?

A good Other Long-Term Liabilities depends on the Travel & Leisure industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Other Long-Term Liabilities mean?

A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Risma and its competitors. Risma's current Other Long-Term Liabilities is MAD29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Risma stock overvalued right now?

Based on GuruFocus' analysis, Risma (CAS:RIS) is currently considered Modestly Undervalued. The stock's GF Value™ is MAD360.85, compared to a current price of MAD320.00 — trading 11.3% below its estimated fair value. The current Other Long-Term Liabilities is MAD29 Mil. Risma's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Other Long-Term Liabilities calculated?

Other Long-Term Liabilities is calculated from a company's financial statements. For Risma (CAS:RIS), the current Other Long-Term Liabilities is MAD29 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Risma (CAS:RIS) Overvalued in 2026?

Based on GuruFocus' analysis, Risma stock appears to be undervalued. The current stock price of MAD320.00 is trading 11.3% below its estimated GF Value™ of MAD360.85. GuruFocus considers Risma to be Modestly Undervalued.

Key valuation signals for CAS:RIS:

Other Long-Term Liabilities: MAD29 Mil
GF Value™: MAD360.85 vs. price of MAD320.00 (11.3% below fair value)
GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the CAS:RIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →